97 related articles for article (PubMed ID: 21323956)
1. Comparison of cadherin-17 expression between primary colorectal adenocarcinomas and their corresponding metastases: the possibility of a diagnostic marker for detecting the primary site of metastatic tumour.
Park JH; Seol JA; Choi HJ; Roh YH; Choi PJ; Lee KE; Roh MS
Histopathology; 2011 Jan; 58(2):315-8. PubMed ID: 21323956
[No Abstract] [Full Text] [Related]
2. Young investigator challenge: Cadherin-17 and SATB2 in cytology specimens: Do these new immunostains help in differentiating metastatic colorectal adenocarcinoma from adenocarcinomas of other origins?
Brandler TC; Jelloul FZ; Soto D; Das K; Rosen L; Bhuiya TA
Cancer Cytopathol; 2015 Dec; 123(12):706-13. PubMed ID: 26671737
[TBL] [Abstract][Full Text] [Related]
3. The Diagnostic Value of Cadherin 17 and CDX2 Expression as Immunohistochemical Markers in Colorectal Adenocarcinoma.
Abouelkhair MB; Mabrouk SH; Zaki SSA; Nada OH; Hakim SA
J Gastrointest Cancer; 2021 Sep; 52(3):960-969. PubMed ID: 32929682
[TBL] [Abstract][Full Text] [Related]
4. Altered expression of CDX2 in colorectal cancers.
Choi BJ; Kim CJ; Cho YG; Song JH; Kim SY; Nam SW; Lee SH; Yoo NJ; Lee JY; Park WS
APMIS; 2006 Jan; 114(1):50-4. PubMed ID: 16499661
[TBL] [Abstract][Full Text] [Related]
5. Isolated adrenal metastasis: a case report.
Bhandare S; Shrikhande S; Bakshi G; Deodhar KK
Indian J Pathol Microbiol; 2014; 57(1):150-1. PubMed ID: 24739860
[No Abstract] [Full Text] [Related]
6. CDX2 as a useful marker of colorectal adenocarcinoma metastases to lung in pre-operative biopsy specimens.
Tanaka S; Saito K; Ito T; Tajima K; Mogi A; Shitara Y; Sano T; Kuwano H
Oncol Rep; 2007 Jul; 18(1):87-92. PubMed ID: 17549351
[TBL] [Abstract][Full Text] [Related]
7. Expression of CDX-2 and Ki-67 in different grades of colorectal adenocarcinomas.
Sen A; Mitra S; Das RN; Dasgupta S; Saha K; Chatterjee U; Mukherjee K; Datta C; Chattopadhyay BK
Indian J Pathol Microbiol; 2015; 58(2):158-62. PubMed ID: 25885126
[TBL] [Abstract][Full Text] [Related]
8. Value of CDX2, villin, and alpha-methylacyl coenzyme A racemase immunostains in the distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma.
Suh N; Yang XJ; Tretiakova MS; Humphrey PA; Wang HL
Mod Pathol; 2005 Sep; 18(9):1217-22. PubMed ID: 15803184
[TBL] [Abstract][Full Text] [Related]
9. Identifying colorectal metastases in liver biopsies: the novel CDX2 antibody is less specific than the cytokeratin 20+/7- phenotype.
Tot T
Med Sci Monit; 2004 May; 10(5):BR139-43. PubMed ID: 15114262
[TBL] [Abstract][Full Text] [Related]
10. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
McCluggage WG; Shah R; Connolly LE; McBride HA
Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
[TBL] [Abstract][Full Text] [Related]
11. CDX-2 and HER-3 expression in canine gastric and colorectal adenocarcinomas.
Doster AR; Yhee JY; Kim JH; Im KS; Sur JH
J Comp Pathol; 2011 Jul; 145(1):12-9. PubMed ID: 21238975
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological significant and prognostic influence of cadherin-17 expression in gastric cancer.
Ito R; Oue N; Yoshida K; Kunimitsu K; Nakayama H; Nakachi K; Yasui W
Virchows Arch; 2005 Oct; 447(4):717-22. PubMed ID: 16044349
[TBL] [Abstract][Full Text] [Related]
13. Differential diagnosis of bladder versus colorectal adenocarcinoma: keratin 7 and GATA3 positivity in nuclear ß-catenin-negative glandular tumours defines adenocarcinoma of the bladder.
Broede A; Oll M; Maurer A; Siegert S; Stoerkel S; Golz R; Schwamborn K; Veeck J; Knuechel R; Gaisa NT;
J Clin Pathol; 2016 Apr; 69(4):307-12. PubMed ID: 26463756
[TBL] [Abstract][Full Text] [Related]
14. LEF-1 is frequently expressed in colorectal carcinoma and not in other gastrointestinal tract adenocarcinomas: an immunohistochemical survey of 602 gastrointestinal tract neoplasms.
Kermanshahi TR; Jayachandran P; Chang DT; Pai R
Appl Immunohistochem Mol Morphol; 2014; 22(10):728-34. PubMed ID: 25394300
[TBL] [Abstract][Full Text] [Related]
15. Tissue-specific cadherin CDH17 is a useful marker of gastrointestinal adenocarcinomas with higher sensitivity than CDX2.
Panarelli NC; Yantiss RK; Yeh MM; Liu Y; Chen YT
Am J Clin Pathol; 2012 Aug; 138(2):211-22. PubMed ID: 22904132
[TBL] [Abstract][Full Text] [Related]
16. SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type.
Moh M; Krings G; Ates D; Aysal A; Kim GE; Rabban JT
Am J Surg Pathol; 2016 Mar; 40(3):419-32. PubMed ID: 26551622
[TBL] [Abstract][Full Text] [Related]
17. Expression of COX-2 and E-cadherin in Tunisian patients with colorectal adenocarcinoma.
Miladi-Abdennadher I; Abdelmaksoud-Dammak R; Ayed-Guerfali DB; Ayadi L; Khabir A; Amouri A; Frikha F; Tahri N; Ellouz S; Frikha M; Sellami-Boudawara T; Mokdad-Gargouri R
Acta Histochem; 2012 Oct; 114(6):577-81. PubMed ID: 22133296
[TBL] [Abstract][Full Text] [Related]
18. LI-cadherin and CDX2: Useful Markers in Metastatic Gastrointestinal Adenocarcinoma Cells in Serous Cavity Effusion.
Ma H; Yu J; Tang J
Appl Immunohistochem Mol Morphol; 2019 Sep; 27(8):e75-e80. PubMed ID: 30095466
[TBL] [Abstract][Full Text] [Related]
19. [Differential diagnostic importance of immunochistochemistry applied at metastases of adenocarcinomas of the peritoneum].
Porjazova E; Zaprjanov Z; Batashki I; Milchev N; Markova D
Akush Ginekol (Sofiia); 2009; 48(5):20-2. PubMed ID: 20198793
[TBL] [Abstract][Full Text] [Related]
20. Distinguishing primary adenocarcinoma of the urinary bladder from secondary involvement by colorectal adenocarcinoma: extended immunohistochemical profiles emphasizing novel markers.
Rao Q; Williamson SR; Lopez-Beltran A; Montironi R; Huang W; Eble JN; Grignon DJ; Koch MO; Idrees MT; Emerson RE; Zhou XJ; Zhang S; Baldridge LA; Cheng L
Mod Pathol; 2013 May; 26(5):725-32. PubMed ID: 23348900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
